Sign in to continue:

Stock Profile: PVLA

Palvella Therapeutics, Inc. (PVLA)

Market: NMS | Currency: USD

Address: N/A

N/A

📈 Palvella Therapeutics, Inc. Historical Chart

📊 Statistics

Analyst 1 Year Price Target: $224.94
Upside/Downside from Analyst Target: 163.70%
Broker Call: 32
Dividend Minimum 3 Year Yield: 0.00%
EPS Growth Range (1Y): 50-100%
Net Income Growth Range (1Y): 25-50%
Revenue Growth Range (1Y): <0%
Upcoming Earnings Date: -

💰 Dividend History

No dividend history available.

📅 Earnings & EPS History for Palvella Therapeutics, Inc.

Date	Reported EPS
2025-11-13	-
2025-08-14	-0.86
2025-05-15	-0.74
2025-03-31	-5.37

📰 Related News & Research

Palvella Therapeutics Announces Positive Phase 3 Results for QTORIN Rapamycin, Prepares NDA Submission and U.S. Launch for Rare Skin Disease Therapies
March 31, 2026

Palvella Therapeutics Announces Landmark FY2025 Results and ...
Palvella Therapeutics QTORIN Rapamycin: Novel Treatment Advancements for Rare Skin Diseases and Vascular Malformations
March 31, 2026

Palvella Therapeutics, Inc. 2025 Annual Report: Key Insights...
Palvella Therapeutics Announces $188 Million Public Offering of 1,600,000 Shares – Underwriting Agreement Details and SEC Filing Information
February 27, 2026

Palvella Therapeutics, Inc. Announces \$200 Million Common S...

🔍 View more Reports